Hot Topics

News

Penn's Gene Therapy Startup Raises Another $50 Million

Funding for cellular therapies that target specific B cells that mediate a wide variety of autoimmune conditions.

Read more
News

National Blood Foundation Early-Career Grant for Dr. Vijay Bhoj

Award for research in the fields of transfusion medicine and cellular therapies.

Read more
publication

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas

Global CAR T Therapy Trial Shows High Rates of Durable Remission for Non-Hodgkin’s Lymphoma: Additional data shows remissions past two years among patients treated in earlier pilot study.

Read more
video

Cancer Immunotherapy Research

20 years of Penn Medicine's "ImmunoRevolution" that has created personalized immunotherapy treatments to reprogram the immune system to recognize and kill cancer cells.

Read more
News

Dr. Bruce Levine Appointed as Deputy Director of Technology Innovation at CCI

New role to coordinate the assessment and integration of new technologies into the continuum of new cellular therapies at the Center for Cellular Immunotherapies (CCI).

Read more
Breaking

FDA Approves Personalized Cellular Therapy for Advanced Leukemia

Landmark decision for the field of cancer immunotherapy for first therapy based on gene transfer approved by the FDA.

Read more